Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology ...
A newly designed optical centrifuge allows scientists to control molecular rotation inside superfluid helium nano-droplets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results